FGN Futuragene

 

TIDMFGN 
 
 
Futuragene PLC 
15 June 2009 
 
? 
 
 
 
 
FUTURAGENE PLC ("FuturaGene" or the "Company") 
 
 
FuturaGene's Wholly Owned Subsidiary, CBD Technologies, Ltd. (FGN's, CBD 
Tech) will co-sponsor the Tree Biotechnology Conference of the International 
Union of Forestry Research Organizations (IUFRO) and present its Biomass Yield 
enhancing technology. 
 
 
Rehovoth, Israel 
15 June, 2009 
 
 
FuturaGene, which develops environmentally friendly solutions that enhance 
yields and improve the processability of plants for forestry, biofuels, biopower 
and agriculture, is to co-sponsor the  upcoming Tree Biotechnology Conference of 
the International Union of Forestry Research Organizations (IUFRO) (June 28th to 
July 2nd, Whistler, Canada).  Dr. Ziv Shani, Vice President Research & 
Development at CBD Technologies, will present the company's Plant Cell Wall 
Modulation Technology for enhancing biomass and increasing pulp yield and 
saccharification.  Dr. Shani will be speaking on Wednesday, July 1st in session 
VI of the conference. 
 
 
"The IUFRO Tree Biotechnology Conference is one of the most prominent gatherings 
of industry and academic players in forest and biomass biotechnology and 
provides an outstanding stage for sharing our perspective and capabilities with 
colleagues in the forestry, biofuel and biopower arenas. We are excited to 
co-sponsor and present at this important event" said Dr. Stanley Hirsch, Group 
CEO, FuturaGene. 
 
 
Dr. Ziv Shani added "As a pioneer of plant cell wall modulation technology, CBD 
Tech has accumulated a vast knowledge base and experience in enhancing plant 
biomass and yield. We have implemented our technology in eucalyptus and poplar, 
as well as other crops, and we are currently conducting several field trials 
around the globe. In this context, we are part of a very small group of 
entities, which have taken agronomic traits from discovery to late stage 
commercial field trials". 
 
 
FuturaGene Plc 
Mark Pritchard, Chairman                                                 +44 (0) 
7802 827 846 
Dr. Stanley Hirsch, Group CEO      +972 544 56 2724 
Evolution Securities 
Neil Elliot      +44 (0) 20 7071 4300 
 
 
About FuturaGene PLC 
 
 
FGN is a leading agricultural biotechnology company focused on research, 
development, and commercialization  of technologies that play key roles in 
substantially improving agronomic  traits of value in plants. In particular the 
Company is focused on the development and commercialization of genetically 
modified plants for improving and protecting yields, and enhancing 
processability and environmental sustainability in the forestry, biofuels, 
biopower and agricultural sectors. In addition to its in-house discovery 
program, FuturaGene licenses intellectual property from leading universities in 
its strategic fields of interest and is exploiting the synergies of these 
technologies with the cell wall modification platform of its wholly owned 
subsidiary, CBD Technologies, Inc. (CBD Tech) in forestry, biofuel, biopower, 
food and feed crops. 
 
CBD Tech has pioneered a modality for modifying plant cell walls, resulting in 
enhanced growth and biomass, increased cellulose, improved fiber properties, 
improved digestibility and processability, and increased yield properties and 
has secured broad intellectual property covering plants with modified cell walls 
showing such altered properties. More information is available at 
www.futuragene.com. 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 NRASFWSMISUSESM 
 

Futuragene (LSE:FGN)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024

Futuragene (LSE:FGN)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024